Prednisone Acetate Tablets
Sponsors
Jiang lindi, Henan University of Traditional Chinese Medicine, Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
AbirateroneHenoch-Schönlein Purpura NephritisMetastatic Castration-resistant Prostate CancerNeoadjuvant Therapy \ High Risk Prostate Cancer \ DocetaxelOligometastatic Prostate CancerProstate CancerProstatectomyTakayasu Arteritis
Phase 1
Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment
NCT03591471
Start: 2014-09-30End: 2018-12-31Target: 500Updated: 2018-07-19
To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
TerminatedNCT05405439
Start: 2022-08-25End: 2023-07-19Updated: 2023-11-03
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
RecruitingNCT06568094
Start: 2024-09-25End: 2027-06-30Target: 100Updated: 2025-12-31
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
RecruitingNCT06689163
Start: 2024-12-11End: 2026-12-31Target: 66Updated: 2025-09-03
Phase 2
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
NCT04869371
Start: 2018-12-12End: 2023-01-01Target: 75Updated: 2022-12-29
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
CompletedNCT04992026
Start: 2021-01-01End: 2024-12-02Updated: 2024-12-05